Y-Intercept (HK)’s Olema Pharmaceuticals OLMA Stock Holding History

Y-Intercept (HK)’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$878K	Buy	+101,658	New	+$1.11M	0.02%	1070
2026 Q2	–	Sell	-90,375	Closed	-$1.35M	–	2044
2026 Q1	$1.35M	Buy	90,375 +53,176	+143%	+$1.18M	0.03%	909
2025 Q4	$930K	Buy	+37,199	New	+$662K	0.02%	1002
2025 Q2	–	Sell	-10,882	Closed	-$40.9K	–	1910
2025 Q1	$40.9K	Sell	10,882 -8,119	-43%	-$40.8K	﹤0.01%	1134
2024 Q4	$111K	Buy	+19,001	New	+$190K	0.01%	1098
2024 Q1	–	Sell	-11,319	Closed	-$159K	–	1646
2023 Q4	$159K	Buy	+11,319	New	+$152K	0.01%	1039

Other funds holding OLMA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Y-Intercept (HK)'s OLMA Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Olema Pharmaceuticals (OLMA) in Q3 2026: 101,658 shares worth $878K. The stake represents 0.02% of the portfolio and ranks #1070 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in OLMA as recently as Q1 2026.

Y-Intercept (HK) first reported a position in OLMA in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.35M in Q1 2026. 12 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

Y-Intercept (HK) held 101,658 shares of Olema Pharmaceuticals worth $878K as of Q3 2026.
Olema Pharmaceuticals was a new Y-Intercept (HK) position in Q3 2026.
Olema Pharmaceuticals made up 0.02% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1070 holding.
Y-Intercept (HK) first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
Y-Intercept (HK)'s Olema Pharmaceuticals position peaked at $1.35M in Q1 2026.
12 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.